Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Clinics ; 67(12): 1463-1468, Dec. 2012. ilus
Artículo en Inglés | LILACS | ID: lil-660476

RESUMEN

OBJECTIVE: Volume replacement in septic patients improves hemodynamic stability. This effect can reduce the inflammatory response. The objective of this study was to evaluate the effect of 7.5% hypertonic saline solution versus 0.9% normal saline solution for volume replacement during an inflammatory response in endotoxemic rats. METHODS: We measured cytokines (serum and gut), nitrite, and lipid peroxidation (TBARS) as indicators of oxidative stress in the gut. Rats were divided into four groups: control group (C) that did not receive lipopolysaccharide; lipopolysaccharide injection without treatment (LPS); lipopolysaccharide injection with saline treatment (LPS +S); and lipopolysaccharide injection with hypertonic saline treatment (LPS +H). Serum and intestine were collected. Measurements were taken at 1.5, 8, and 24 h after lipopolysaccharide administration. RESULTS: Of the four groups, the LPS +H group had the highest survival rate. Hypertonic saline solution treatment led to lower levels of IL-6, IL-10, nitric oxide, and thiobarbituric acid reactive substances compared to 0.9% normal saline. In addition, hypertonic saline treatment resulted in a lower mortality compared to 0.9% normal saline treatment in endotoxemic rats. Volume replacement reduced levels of inflammatory mediators in the plasma and gut. CONCLUSION: Hypertonic saline treatment reduced mortality and lowered levels of inflammatory mediators in endotoxemic rats. Hypertonic saline also has the advantage of requiring less volume replacement.


Asunto(s)
Animales , Masculino , Ratas , Endotoxemia/metabolismo , Interleucinas/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Nitritos/metabolismo , Estrés Oxidativo , Solución Salina Hipertónica/farmacología , Síndrome de Respuesta Inflamatoria Sistémica/terapia , Modelos Animales de Enfermedad , Endotoxemia/inducido químicamente , Hemodinámica/efectos de los fármacos , Mediadores de Inflamación/sangre , Enfermedades Inflamatorias del Intestino/metabolismo , Enfermedades Inflamatorias del Intestino/patología , Enfermedades Inflamatorias del Intestino/prevención & control , /metabolismo , /metabolismo , Lipopolisacáridos/administración & dosificación , Distribución Aleatoria , Ratas Wistar , Análisis de Supervivencia , Síndrome de Respuesta Inflamatoria Sistémica/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA